Further, although acute IFN-γ signaling is essential for anti-tumor immunity, previous studies have demonstrated that prolonged activation of the IFN-γ signaling pathway can upregulate expression of the immune checkpoint inhibitor PD-L1, leading to tumor immune evasion [58–60]. The gene discussed is IFNG; the disease is neoplasm.